Juliana Maria Faccioli Sicchieri

Juliana Maria Faccioli Sicchieri

Auto-generated profile, based on publicly available information

Juliana Maria Faccioli Sicchieri

Department of Health Sciences, School of Medicine of Ribeirão Preto, University of São Paulo, Brazil

Research Focus & Metrics

Academic Career Length

7Years (2020-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
7 December 2022 in Reviews in Endocrine and Metabolic Disorders
Verified
Journal Article
Closed access
PDF file
BSBruna Ramos da Silva¹
Bruna Ramos da Silva¹
COCamila Estefani Orsso
Camila Estefani Orsso
Maria Cristina GonzalezMaria Cristina Gonzalez
Maria Cristina Gonzalez
JSJuliana Maria Faccioli Sicchieri³
Juliana Maria Faccioli Sicchieri³
MMMirele Mialich
Mirele Mialich
CPCarla Prado
Carla Prado

1 February 2020 in Nutrition
Verified
Journal Article
Closed access
APAna Paula Pagano
Ana Paula Pagano
JSJuliana Maria Faccioli Sicchieri
Juliana Maria Faccioli Sicchieri
ISIsabela Laurencio Schiavoni
Isabela Laurencio Schiavoni
DBDaniel Barbeiro
Daniel Barbeiro
CMCamila Sanches Manca
Camila Sanches Manca
PCPaula Garcia Chiarello
Paula Garcia Chiarello

31 January 2020 in Einstein (São Paulo)
Verified
Journal Article
Open access
PDF file
JBJuliana Bernardo Barban
Juliana Bernardo Barban
BSBelinda Pinto Simões
Belinda Pinto Simões
BMBruna Del Guerra de Carvalho Moraes
Bruna Del Guerra de Carvalho Moraes
CACássia Rehem da Anunciação
Cássia Rehem da Anunciação
CRCristiane Santos da Rocha
Cristiane Santos da Rocha
APAndrea Pereira
Andrea Pereira
The nutritional status of patients submitted to hematopoietic stem cell transplant is considered an independent risk factor, which may influence on quality of life and tolerance to the proposed treatment. The impairment of nutritional status during hematopoietic stem cell transplant occurs mainly due to the adverse effects resulting from conditioning to which the patient is subjected. Therefore, adequate nutritional evaluation and follow-up during hematopoietic stem cell transplant are essential. To emphasize the importance of nutritional status and body composition during treatment, as well as the main characteristics related to the nutritional assessment of the patient, the Brazilian Consensus on Nutrition in Hematopoietic Stem Cell Transplant: Adults was prepared, aiming to standardize and update Nutritional Therapy in this area. Dietitians, nutrition physicians and hematologists from 15 Brazilian centers thar are references in hematopoietic stem cell transplant took part.

11 November 2022 in Clinical Nutrition ESPEN
Verified
Journal Article
Closed access
TGThauany Nantes Guiráo
Thauany Nantes Guiráo
SOSofia Teixeira Prates Oliveira
Sofia Teixeira Prates Oliveira
ABAmanda Escobar Bezerra
Amanda Escobar Bezerra
BFBruna Silvestre Françoso
Bruna Silvestre Françoso
BSBárbara David dos Santos
Bárbara David dos Santos
PCPaula Garcia Chiarello
Paula Garcia Chiarello

19 December 2022 in Journal of the Academy of Nutrition and Dietetics
Verified
Journal Article
Closed access
JSJuliana Maria Faccioli Sicchieri
Juliana Maria Faccioli Sicchieri
BGBeatriz Miranda Campos Gracia
Beatriz Miranda Campos Gracia
ISIsabela Laurencio Schiavoni
Isabela Laurencio Schiavoni
APAna Paula Pagano
Ana Paula Pagano
ANAnderson Marliere Navarro
Anderson Marliere Navarro

13 February 2026 in Hematology, Transfusion and Cell Therapy
Verified
Journal Article
Open access
BFBruna Silvestre Françoso
Bruna Silvestre Françoso
ISIsabela Laurêncio Schiavoni
Isabela Laurêncio Schiavoni
TGThauany Nantes Guirao
Thauany Nantes Guirao
BSBarbara David dos Santos
Barbara David dos Santos
TCThalita Costa
Thalita Costa
JSJuliana Maria Faccioli Sicchieri
Juliana Maria Faccioli Sicchieri
Allogeneic hematopoietic stem cell transplantation is a viable therapeutic option for several serious diseases however it is a high-risk procedure because it involves high-toxicity protocols with many adverse effects. Existing factors, such as the underlying disease and nutritional status, may influence the outcome. The objective of this study was to evaluate the Nutritional Risk Index as a prognostic tool by correlating it with body mass index, nutritional status, and clinical outcomes in patients undergoing hematopoietic stem cell transplantation. This single center retrospective study was conducted collected sociodemographic, anthropometric, biochemical, and clinical data before conditioning and 30 days post-transplantation. Statistical analyses were performed using the Mann-Whitney test and Spearman's correlation. Overall survival was estimated using the Kaplan-Meier method, with comparisons conducted via the Gehan-Breslow-Wilcoxon test. A Cox Proportional Hazards regression analysis was employed to identify factors associated with mortality; variables demonstrating a p-value ≤0.20 in the univariate analysis were included in the multivariate model. For all analyses, statistical significance was defined as a p-value <0.05. Seventy-seven participants were included, with an average age of 41 years. According to the nutritional risk index, the entire sample was classified as having severe nutritional risk. The body mass index showed that 6.4 % were malnourished, 19.4 % were obese, and 12.9 % had hypoalbuminemia. The estimated survival curve identified a significant difference for patients aged <45 years with survival being significantly longer (p-value = 0.01). Higher albumin levels (≥3.5) after transplantation were associated with longer survival (p-value = 0.04). Sex, body mass index, albumin level before conditioning, and graft-versus-host disease showed no significant differences in terms of survival. Albumin levels ≥3.5 g/dL after transplantation were marginally associated with a lower mortality risk and malignant disease showed a trend toward increased mortality. These findings underscore the clinical utility of prognostic indices, such as the Nutritional Risk Index and albumin levels, during the pre-transplant period, emphasizing the necessity for early nutritional interventions in hematopoietic stem cell transplantation patients.